https://orcid.org/0000-0001-8406-4121
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Reagan A. Collins, Nandini Ray, Kelly Ratheal & Athos Colon. (2022) Severe post-COVID-19 costochondritis in children. Baylor University Medical Center Proceedings 35:1, pages 56-57.
Read now
Read now
Articles from other publishers (20)
Sepideh Hejazi, Zohreh Jahani, Sepideh Elyasi, Davoud Salarbashi & Mona Kabiri. (2024) The Efficacy of Colchicine as an Adjunct Therapy in
Non-hospitalized COVID-19 Patients: A Randomized
Placebo-Controlled Trial. Recent Advances in Anti-Infective Drug Discovery 19:3, pages 254-263.
Crossref
Crossref
Leo F. Buckley & Peter Libby. (2024) Colchicine’s Role in Cardiovascular Disease Management. Arteriosclerosis, Thrombosis, and Vascular Biology 44:5, pages 1031-1041.
Crossref
Crossref
Lisa K Stamp, Carl Horsley, Leanne Te Karu, Nicola Dalbeth & Murray Barclay. (2024) Colchicine: the good, the bad, the ugly and how to minimize the risks. Rheumatology 63:4, pages 936-944.
Crossref
Crossref
Zahra Alipour, Somayeh Zarezadeh & Ali Akbar Ghotbi-Ravandi. (2023) The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. Planta Medica 90:03, pages 172-203.
Crossref
Crossref
Johanna Bausson, Nicolas Keller, Jean-Jacques Von Hunolstein, Matthieu Sacrez, Bruno Michel, Bénédicte Gourieux, Marion Fourtage & Renaud Felten. (2024) Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease. RMD Open 10:1, pages e003872.
Crossref
Crossref
Nicolas Hulscher, Brian C Procter, Cade Wynn & Peter A McCullough. (2023) Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus.
Crossref
Crossref
Stefan Mark Nidorf. (2023) Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease. Clinical Therapeutics 45:11, pages 1029-1033.
Crossref
Crossref
Matthew T. J. Halma, Christof Plothe, Paul Marik & Theresa A. Lawrie. (2023) Strategies for the Management of Spike Protein-Related Pathology. Microorganisms 11:5, pages 1308.
Crossref
Crossref
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede & Anil Kumar Saxena. (2022) Repurposing of Chemotherapeutics to Combat COVID-19. Current Topics in Medicinal Chemistry 22:32, pages 2660-2694.
Crossref
Crossref
Qinglin Cheng, Gang Zhao, Junfang Chen, Qingjun Jia & Zijian Fang. (2022) Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials. Medicine 101:41, pages e30998.
Crossref
Crossref
Mohammed H. Alqarni, Faiyaz Shakeel, Tariq M. Aljarba, Maged S. Abdel-Kader, Hala H. Zaatout, Sultan Alshehri & Prawez Alam. (2022) Determination of Colchicine in Pharmaceutical Formulations, Traditional Extracts, and Ultrasonication-Based Extracts of Colchicum autumnale Pleniflorum (L.) Using Regular and Greener HPTLC Approaches: A Comparative Evaluation of Validation Parameters. Plants 11:13, pages 1767.
Crossref
Crossref
Natalie Schellack, Morné Strydom, Michael S. Pepper, Candice L. Herd, Candice Laverne Hendricks, Elmien Bronkhorst, Johanna C. Meyer, Neelaveni Padayachee, Varsha Bangalee, Ilse Truter, Andrea Antonio Ellero, Thulisa Myaka, Elysha Naidoo & Brian Godman. (2022) Social Media and COVID-19—Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics. Antibiotics 11:4, pages 445.
Crossref
Crossref
Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Apostolis Papaefthymiou, Eleftheria Economidou, Elpidoforos S. Soteriades, Elisabeth Vardaka, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Dimitrios David Papazoglou & Michael Doulberis. (2022) Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic. Medicina 58:2, pages 309.
Crossref
Crossref
Philip C. Robinson, Robert Terkeltaub, Michael H. Pillinger, Binita Shah, Vangelis Karalis, Eleni Karatza, David Liew, Massimo Imazio, Jan H. Cornel, Peter L. Thompson & Mark Nidorf. (2022) Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. The American Journal of Medicine 135:1, pages 32-38.
Crossref
Crossref
Abdiel Absalón-Aguilar, Marina Rull-Gabayet, Alfredo Pérez-Fragoso, Nancy R. Mejía-Domínguez, Carlos Núñez-Álvarez, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio, Alfredo Ponce-de-León, Fernanda González-Lara, Eduardo Martín-Nares, Sharon Montesinos-Ramírez, Martha Ramírez-Alemón, Pamela Ramírez-Rangel, Manlio F. Márquez, Juan Carlos Plata-Corona, Guillermo Juárez-Vega, Diana Gómez-Martín & Jiram Torres-Ruiz. (2021) Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID). Journal of General Internal Medicine 37:1, pages 4-14.
Crossref
Crossref
Ibadete Bytyçi & Maciej Banach. 2022. Cardiovascular Complications of COVID-19. Cardiovascular Complications of COVID-19
317
329
.
Noha A. Kamel, Nasser S. M. Ismail, Ibrahim S. Yahia & Khaled M. Aboshanab. (2021) Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis. Medicina 58:1, pages 20.
Crossref
Crossref
Hamdah M. Al Nebaihi, Tyson S. Le, Neal M. Davies & Dion R. Brocks. (2021) Liquid Chromatography Tandem Mass Spectrometric Analytical Method for Study of Colchicine in Rats Given Low Doses. Processes 9:11, pages 2007.
Crossref
Crossref
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Konstantinos Raisakis, Charalampos Kossyvakis, Andreas Kaoukis, Fotis Kolokathis, Gerasimos Deftereos, Konstantinos E. Iliodromitis, Dimitrios Avramides, Harilaos Bogossian, Gerasimos Siasos, George Giannopoulos, Bernhard Reimers, Alexandra Lansky, Jean-Claude Tardif & Spyridon Deftereos. (2021) Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine. Journal of Clinical Medicine 10:21, pages 5128.
Crossref
Crossref
Fatemeh Sodeifian, Zahra Sadat Seyedalhosseini, Naghmeh Kian, Mahya Eftekhari, Shaghayegh Najari, Mehdi Mirsaeidi, Yeganeh Farsi & Mohammad Javad Nasiri. (2021) Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Frontiers in Medicine 8.
Crossref
Crossref